As of 2025-10-23, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -21.75 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Evelo Biosciences Inc is -4,349,810.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 4,349,810.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -21.75 - -21.75 | -21.75 | -4,349,810.00% |
| P/E | (22.18) - (33.28) | (27.73) | -5545979.6% |
| DDM - Stable | (0.02) - (0.04) | (0.03) | -5573.1% |
| DDM - Multi | (0.03) - (0.04) | (0.03) | -6659.7% |
| Market Cap (mil) | 0.00 |
| Beta | -0.15 |
| Outstanding shares (mil) | 7.57 |
| Enterprise Value (mil) | 0.00 |
| Market risk premium | 4.60% |
| Cost of Equity | 35,416.17% |
| Cost of Debt | 5.00% |
| WACC | 8.06% |